Burden of moderate-to-severe atopic dermatitis on work productivity and the impact of dupilumab on work productivity in Japanese patients: A single-center retrospective study

被引：0
|
作者：
Sakurai, Emi [1 ]
Kamata, Masahiro [1 ]
Uchida, Hideaki [1 ]
Tada, Yayoi [1 ]
机构：
[1] Teikyo Univ, Sch Med, Tokyo, Japan
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
41898
引用
收藏
页码：AB23 / AB23
页数：1
相关论文
共 50 条
  • [1] Clinical burden and work productivity impairment in moderate-to-severe atopic dermatitis patients in the United States
    Feldman, Steven R.
    Guerin, Annie
    Gauthier-Loiselle, Marjolaine
    Claxton, Ami J.
    Hazra, Nisha C.
    Meng, Yan
    Gallant, Kirsten
    Balu, Sanjeev
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II45 - II46
  • [2] Impact of 1-year treatment with dupilumab on work productivity in Japanese patients with atopic dermatitis
    Sakurai, Emi
    Kamata, Masahiro
    Uchida, Hideaki
    Okada, Yoshiki
    Suzuki, Shoya
    Takeshima, Ryosuke
    Ito, Makoto
    Watanabe, Ayu
    Mizukawa, Itsumi
    Egawa, Shota
    Chijiwa, Chika
    Hiura, Azusa
    Fukaya, Saki
    Hayashi, Kotaro
    Fukuyasu, Atsuko
    Tanaka, Takamitsu
    Ishikawa, Takeko
    Tada, Yayoi
    EXPERIMENTAL DERMATOLOGY, 2024, 33 (02)
  • [3] Laboratory markers of dupilumab patients with moderate-to-severe atopic dermatitis: a single-center, real-world study
    Hawkins, K.
    Sharma, D.
    Shokrian, N.
    Piontkowski, A.
    Ungar, B.
    Guttman-Yassky, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S162 - S162
  • [4] A study into the drug dupilumab in Japanese adults with moderate-to-severe atopic dermatitis
    不详
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (01) : E4 - E4
  • [5] Dupilumab for atopic dermatitis treatment: A single-center retrospective study
    Yasar, Gulbin
    Bilgic, Asli
    Yilmaz, Ertan
    TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2022, 56 (01): : 12 - 16
  • [6] Use of Dupilumab in 543 Adult Patients With Moderate-to-Severe Atopic Dermatitis: A Multicenter, Retrospective Study
    Nettis, E.
    Ferrucci, S. M.
    Ortoncelli, M.
    Pellacani, G.
    Foti, C.
    Di Leo, E.
    Patruno, C.
    Rongioletti, F.
    Argenziano, G.
    Macchia, L.
    Tavecchio, S.
    Napolitano, M.
    Ribero, S.
    Bonzano, L.
    Romita, P.
    Di Bona, D.
    Nistico, S. P.
    Piras, V
    Calabrese, G.
    Detoraki, C.
    Carbonara, M.
    Fabbrocini, G.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2022, 32 (02) : 124 - 132
  • [7] WORK PRODUCTIVITY IN BRAZILIAN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS
    Lopes, N.
    Antonio, J. R.
    Fabricio, L.
    Azulay-Abulafia, L.
    Dias, L. L.
    Pertel, P.
    VALUE IN HEALTH, 2017, 20 (09) : A902 - A902
  • [8] Impact of disease severity on work productivity and activity impairment in Japanese patients with atopic dermatitis
    Yano, Chizuko
    Saeki, Hidehisa
    Ishiji, Takaoki
    Ishiuji, Yozo
    Sato, Junko
    Tofuku, Yukari
    Nakagawa, Hidemi
    JOURNAL OF DERMATOLOGY, 2013, 40 (09): : 736 - 739
  • [9] Dupilumab for moderate-severe atopic dermatitis: a real-world, single-center retrospective study of 122 patients in the United States
    Emmerich, Veronica K.
    Williams, Josiah A.
    Hrin, Matthew L.
    Feldman, Steven R.
    Strowd, Lindsay C.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024, 63 (04) : 524 - 525
  • [10] WORK PRODUCTIVITY IN ADULT PATIENTS WITH ATOPIC DERMATITIS
    Beretzky, Z.
    Rencz, F.
    Koszoru, K.
    Hajdu, K.
    Borza, J.
    Bodai, K.
    Szegedi, A.
    Sardy, M.
    Brodszky, V
    VALUE IN HEALTH, 2022, 25 (01) : S117 - S117
12345